Inhibition of translocation of nascent apolipoprotein B across the endoplasmic reticulum membrane is associated with selective inhibition of the synthesis of apolipoprotein B

J Biol Chem. 2000 Sep 1;275(35):27399-405. doi: 10.1074/jbc.M000554200.

Abstract

In HepG2 cells, inhibition of apolipoprotein B100 (apoB) translocation across the endoplasmic reticulum by an microsomal triglyceride transfer protein (MTP) inhibitor (CP-10447) in the presence of N-acetyl-leucinyl-norleucinal, a proteasomal inhibitor, results in accumulation of newly synthesized apoB in the translocation channel. Here we demonstrated that such accumulation led to a specific reduction of apoB synthesis. ApoB mRNA levels remained unchanged, but we observed reduced rates of elongation of nascent apoB in puromycin-synchronized cells pretreated with MTP inhibitor. This observation was consistent with a longer half-ribosome transit time for the synthesis of apoB in MTP-inhibited cells. Initiation of translation of apoB mRNA was not impaired by MTP inhibition. Overall, these findings suggest that translocation arrest of apoB in the endoplasmic reticulum channel can exert a selective and negative effect on the synthesis of apoB at the stage of elongation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Apolipoproteins B / antagonists & inhibitors
  • Apolipoproteins B / biosynthesis
  • Apolipoproteins B / genetics
  • Apolipoproteins B / metabolism*
  • Biological Transport
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / metabolism
  • Cell Line
  • Endoplasmic Reticulum / metabolism*
  • Humans
  • Leupeptins / pharmacology
  • Methaqualone / analogs & derivatives
  • Methaqualone / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Ribosomes / metabolism

Substances

  • 4-bromomethaqualone
  • Apolipoproteins B
  • Carrier Proteins
  • Leupeptins
  • RNA, Messenger
  • microsomal triglyceride transfer protein
  • acetylleucyl-leucyl-norleucinal
  • Methaqualone